Literature DB >> 2768269

Ascorbic acid within chromaffin granules. In situ kinetics of norepinephrine biosynthesis.

K R Dhariwal1, P Washko, W O Hartzell, M Levine.   

Abstract

Ascorbic acid requirements for norepinephrine biosynthesis were investigated in intact bovine chromaffin granules using the physiologic substrate dopamine and a novel coulometric electrochemical detection high pressure liquid chromatography system for ascorbic acid. 10 mM external dopamine, 1 mM Mg-ATP, and 1 mM ascorbic acid produced maximal norepinephrine biosynthesis without granule lysis. When external ascorbic acid was omitted, intragranular ascorbic acid was consumed in a 1:1 ratio with respect to norepinephrine biosynthesis. The initial concentration of intragranular ascorbic acid was 10.5 mM, which was depleted in stepwise fashion to 15 lower concentrations over the range of 9.2-0.2 mM. Chromaffin granules containing these varying concentrations of intragranular ascorbic acid were then incubated with 1 mM exogenous ascorbic acid, and norepinephrine biosynthesis from dopamine was determined. The apparent Km of norepinephrine biosynthesis for intragranular ascorbic acid was 0.57 mM by Eadie-Hofstee analysis and 0.68 mM by Lineweaver-Burk analysis. These data indicate that intragranular ascorbic acid is available and required for norepinephrine biosynthesis, that ascorbic acid is a true co-substrate for dopamine beta-monooxygenase, and that intragranular ascorbic acid is maintained by extragranular ascorbic acid. Continued norepinephrine biosynthesis in granules is dependent on both intragranular and extragranular concentrations of the vitamin. Furthermore, in situ kinetics of dopamine beta-monooxygenase for ascorbic acid may be most accurately determined using intact granules and the true physiologic substrate.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2768269

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Natural electrophoresis of norepinephrine and ascorbic acid.

Authors:  P F Dillon; R S Root-Bernstein; P R Sears; L K Olson
Journal:  Biophys J       Date:  2000-07       Impact factor: 4.033

2.  Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance.

Authors:  M Levine; C Conry-Cantilena; Y Wang; R W Welch; P W Washko; K R Dhariwal; J B Park; A Lazarev; J F Graumlich; J King; L R Cantilena
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

3.  Ascorbic acid efficiently enhances neuronal synthesis of norepinephrine from dopamine.

Authors:  James M May; Zhi-Chao Qu; Rafal Nazarewicz; Sergey Dikalov
Journal:  Brain Res Bull       Date:  2012-09-26       Impact factor: 4.077

Review 4.  Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries.

Authors:  Mark Levine; Sebastian J Padayatty; Michael Graham Espey
Journal:  Adv Nutr       Date:  2011-03-10       Impact factor: 8.701

5.  Abnormal urinary loss of vitamin C in diabetes: prevalence and clinical characteristics of a vitamin C renal leak.

Authors:  Ifechukwude Ebenuwa; Pierre-Christian Violet; Sebastian Padayatty; Yaohui Wang; Yu Wang; Henry Sun; Preston Adhikari; Sheila Smith; Hongbin Tu; Mahtab Niyyati; Kenneth Wilkins; Mark Levine
Journal:  Am J Clin Nutr       Date:  2022-07-06       Impact factor: 8.472

Review 6.  Vitamin C: the known and the unknown and Goldilocks.

Authors:  S J Padayatty; M Levine
Journal:  Oral Dis       Date:  2016-04-14       Impact factor: 3.511

7.  Ascorbic acid accumulation and transport in human fibroblasts.

Authors:  R W Welch; P Bergsten; J D Butler; M Levine
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

8.  Human cytochrome b561: a revised hypothesis for conformation in membranes which reconciles sequence and functional information.

Authors:  M Srivastava; K R Gibson; H B Pollard; P J Fleming
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

9.  Losing and finding a way at C: new promise for pharmacologic ascorbate in cancer treatment.

Authors:  Mark Levine; Michael Graham Espey; Qi Chen
Journal:  Free Radic Biol Med       Date:  2009-04-08       Impact factor: 7.376

10.  Mutations in CYB561 Causing a Novel Orthostatic Hypotension Syndrome.

Authors:  Maarten P van den Berg; Rowida Almomani; Italo Biaggioni; Martijn van Faassen; Pim van der Harst; Herman H W Silljé; Irene Mateo Leach; Marc H Hemmelder; Gerjan Navis; Gert Jan Luijckx; Arjan P M de Brouwer; Hanka Venselaar; Marcel M Verbeek; Paul A van der Zwaag; Jan D H Jongbloed; J Peter van Tintelen; Ron A Wevers; Ido P Kema
Journal:  Circ Res       Date:  2018-01-17       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.